[Positive lists/negative lists from the viewpoint of clinical pharmacology].
Drug lists reduce freedom of choice, but are a logical consequence when drugs are prescribed, which are of no proven value. The current prescribing behaviour is the consequence of insufficient training in clinical pharmacology in medical schools and postgraduate education. Positive lists have shown to be of significant value for hospitals in order to reduce the number of drugs available, which brings safety advantages for the patient, improves in depth knowledge of the physician and reduces stock keeping for the pharmacy.
Frölich
J C
JC
Institut für Klinische Pharmakologie, Medizinische Hochschule, Hannover.
D003479:Curriculum; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D011307:Drug Prescriptions; D004503:Education, Medical, Graduate; D005572:Formularies, Hospital as Topic; D005858:Germany; D006801:Humans; D010601:Pharmacology, Clinical / Q000193:education; D010606:Pharmacy and Therapeutics Committee / Q000331:legislation & jurisprudence*; D017410:Practice Guidelines as Topic; D011785:Quality Assurance, Health Care / Q000331:legislation & jurisprudence*
Positiv-Listen/Negativ-Listen aus der Sicht der Klinischen Pharmakologie.